ISB News

ISB Researcher Featured in Bio-IT World

Congrats to Sheila Reynolds (Shmulevich Lab) on being featured on the Bio-IT World Conference site for her presentation on ISB’s Cancer Genomics Cloud project. Read the Q&A here. Excerpt below:

Cancer Genome Analysis at the Institute for Systems Biology

Q1: How did your background in signal processing and machine learning lead you to work in cancer genome analysis at the Institute for Systems Biology in Seattle, Washington?

After working in industry for 15 years (spanning sonar signal processing and cellular telecommunications), I decided to go back to school to earn a Ph.D. While doing research in natural language processing in the Electrical Engineering department at the University of Washington, I became interested in the field of computational biology where many of the same methods were being applied to understand and “parse” DNA and protein sequences. When I completed my Ph.D., I was offered the opportunity to come to ISB and be a part of the TCGA GDAC.

Q2: The ISB is one of The Cancer Genome Atlas (TCGA) network’s Genome Data Analysis Centers. What kind of resources there support your work?

I played an active role in our TCGA GDAC since its inception, and the deep familiarity that I (and others on the ISB-CGC team) gained through that work — both with the types of data being generated by the TCGA program and the types of analyses performed by each working group leading up to the publication of each of the tumor-specific “marker papers” — has really guided our efforts in building the ISB-CGC platform. Our goal with the ISB-CGC is to provide a cloud-based framework and to develop tools that will make these data and analyses more accessible to a wider range of researchers while continuously exploring how best to make use of the variety of technologies being deployed by Google on their Cloud Platform.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.